CIK 0000009326 · Chemicals & Allied Products (SIC 2800) · Nasdaq · incorporated in MD · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 1.0 B | 942.4 M | ||
| Net income (USD) | 84.6 M | 79.7 M | ||
| Diluted EPS (USD/shares) | 4.75 | 3.25 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-24 | 3 | FORM 3 | 2026-09-16 |
| 2026-07-31 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-31 | 8-K | 8-K items 2.02,9.01 | 2026-07-31 |
| 2026-07-27 | 8-K | 8-K items 1.01,2.03,9.01 | 2026-07-24 |
| 2026-06-22 | 8-K | 8-K items 5.07 | 2026-06-18 |
| 2026-06-18 | 11-K | 11-K | 2025-12-31 |
| 2026-04-30 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-30 | 8-K | 8-K items 2.02,9.01 | 2026-04-30 |
| 2026-04-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-28 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-04-27 | DEFA14A | DEFA14A | |
| 2026-04-27 | DEF 14A | DEF 14A | 2026-06-18 |
| 2026-04-07 | 3 | FORM 3 | 2026-04-01 |
| 2026-03-26 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-02-20 | 10-K | 10-K | 2025-12-31 |
| 2026-02-20 | 8-K | 8-K items 2.02,9.01 | 2026-02-20 |
| 2026-02-19 | 8-K | 8-K items 5.02,9.01 | 2026-02-12 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
| 2026-02-13 | 4 | FORM 4 | 2026-02-11 |
Forms on file (last 1,000): 4 514, 8-K 161, SC 13G/A 66, 10-Q 56, 3 30, 4/A 29, 144 22, 11-K 19. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=BCPC (0.002 USD), /gw/filings/filings?ticker=BCPC&form=8-K, /gw/filings/facts?ticker=BCPC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange